Skip to main content
PRME
NASDAQ Life Sciences

Prime Medicine Prices $125M Offering at $3.50, a Discount to Monday's Close

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.76
Mkt Cap
$707.37M
52W Low
$2.67
52W High
$5.91
52W Position info
41% above low
Off High info
36% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

PRME sits 41% above its 52-week low of $2.67.

Summary

Prime Medicine priced its underwritten common stock offering at $3.50 a share for 35,714,286 shares, grossing roughly $125 million before the 30-day option for up to 5.4 million additional shares. The price is below the $3.7595 last sale, so buyers are getting a modest discount and existing holders face dilution. Jefferies, TD Cowen and Goldman Sachs are acting as joint book-running managers for the offering, which is expected to close on or about Nov. 12. This follows Monday's launch of the $125 million deal and the 8-K disclosing about $61.2 million of unrestricted cash at September 30 — the raise roughly doubles the balance sheet of a company that has carried a going concern warning. The cash buys runway for the pipeline: PM647 cleared its IND in September and the first patient was dosed in the PM577a Wilson's disease trial in late October.

At the time of this announcement, PRME was trading at $3.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $707.4M. The 52-week trading range was $2.67 to $5.91. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PRME - Latest Insights

PRME
Nov 10, 2026, 4:43 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $3.79
Real-time Price: $3.76 info
Change: -$0.0305 (-0.80%) info
Market Cap: $707.37M info
PRME
Nov 10, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.80
Real-time Price: $3.76 info
Change: -$0.0405 (-1%) info
Market Cap: $707.37M info
PRME
Nov 10, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.81
Real-time Price: $3.76 info
Change: -$0.0506 (-1%) info
Market Cap: $707.37M info
PRME
Oct 28, 2026, 1:53 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.16
Real-time Price: $3.76 info
Change: -$1.40 (-27%) info
Market Cap: $707.37M info
PRME
Sep 24, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.38
Real-time Price: $3.76 info
Change: +$0.3793 (+11%) info
Market Cap: $707.37M info